IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
25.61
+0.82 (3.31%)
Dec 20, 2024, 4:00 PM EST - Market closed

IDEAYA Biosciences Revenue

IDEAYA Biosciences had revenue of $3.92M in the twelve months ending September 30, 2024, down -83.30% year-over-year. In the year 2023, IDEAYA Biosciences had annual revenue of $23.39M, down -54.08%.

Revenue (ttm)
$3.92M
Revenue Growth
-83.30%
P/S Ratio
n/a
Revenue / Employee
$31,629
Employees
124
Market Cap
2.21B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202323.39M-27.55M-54.08%
Dec 31, 202250.93M22.99M82.28%
Dec 31, 202127.94M8.40M43.01%
Dec 31, 202019.54M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ardent Health Partners 5.71B
CONMED 1.29B
Azenta 656.32M
NeoGenomics 644.12M
Beam Therapeutics 349.64M
GeneDx Holdings 267.23M
Ligand Pharmaceuticals 152.42M
Iovance Biotherapeutics 90.86M
Revenue Rankings